New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
06:10 EDTOCROmnicare upgraded to Buy from Neutral at UBS
UBS upgraded Omnicare due to valuation and said it now believes there is a large generic Namenda XR opportunity in 2016. Price target is $64.
News For OCR From The Last 14 Days
Check below for free stories on OCR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 11, 2014
10:00 EDTOCROn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:15 EDTOCROmnicare upgraded at Goldman
Subscribe for More Information
05:32 EDTOCROmnicare upgraded to Buy from Neutral at Goldman
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use